Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Total Liabilities ₹405 Cr₹378 Cr₹308 Cr₹184 Cr₹181 Cr

What is the latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹405 Cr based on Mar2024 Consolidated results.
Year Total Liabilities
Mar2024₹405 Cr
Mar2023₹378 Cr
Mar2022₹308 Cr
Mar2017₹184 Cr
Mar2016₹181 Cr

How is Total Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Liabilities % Change
Mar2024 ₹405 Cr
7.10
Mar2023 ₹378 Cr
22.58
Mar2022 ₹308 Cr
67.59
Mar2017 ₹184 Cr
1.81
Mar2016 ₹181 Cr -

Compare Total Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,616.8 Cr 1.5% -4.1% -17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹379,191.0 Cr 1% -0.9% -13% Stock Analytics
DIVIS LABORATORIES ₹159,973.0 Cr -1.6% -1.8% 17.9% Stock Analytics
CIPLA ₹124,507.0 Cr -1.8% 3.7% -6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,175.0 Cr 0.7% 2.4% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,355.0 Cr -0.6% 4.5% -6.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1.5%

-4.1%

-17.9%

SENSEX

0.5%

0.1%

-2.1%


You may also like the below Video Courses